✦ LIBER ✦

P53 codon 72 polymorphism and gastric cancer: A meta-analysis of the literature

✍ Scribed by Yong Zhou; Ni Li; Wen Zhuang; Guan-Jian Liu; Tai-Xiang Wu; Xun Yao; Liang Du; Mao-Ling Wei; Xiao-Ting Wu

Publisher: John Wiley and Sons
Year: 2007
Tongue: French
Weight: 234 KB
Volume: 121
Category: Article
ISSN: 0020-7136
DOI: 10.1002/ijc.22833

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Studies investigating the association between p53 codon 72 polymorphism and gastric cancer risk report conflicting results. The objective of this study was to quantitatively summarize the evidence for such a relationship. Two investigators independently searched the Medline and Embase databases. This meta‐analysis included 12 case‐control studies, which included 1,665 gastric cancer cases and 2,358 controls. The combined results based on all studies showed that there was no significant difference in genotype distribution [Arg/Arg odds ratio (OR) = 0.96, 95% confidence interval (CI) = 0.79, 1.16; Pro/Pro (OR = 1.21, 95% CI = 0.92, 1.58); Pro/Arg (OR = 0.95, 95% CI = 0.79, 1.14)] between gastric cancer and noncancer patients. When stratifying for race, results were similar except that patients with gastric cancer had a significantly lower frequency of Arg/Arg (OR = 0.84, 95% CI = 0.72, 0.99) than noncancer patients among Asians. Stratified the various studies by the location, stage, Lauren's classification, and histological differentiation of gastric cancer, we found that (i) patients with cardia gastric cancer had a significantly higher frequency of Pro/Pro (OR = 3.20, 95% CI = 1.46,7.01) than those with noncardia gastric cancer among Asians; (ii) patients with advanced (stage III/IV) gastric cancer had a significantly higher frequency of Arg/Arg (OR = 1.48, 95% CI = 1.01, 2.16) than those with early (stage I/II) gastric cancer among Asians; (iii) patients with poor differentiation had a significantly lower frequency of Pro/Pro (OR = 0.13, 95% CI = 0.03, 0.64) than those with well differentiation among Caucasians. This meta‐analysis suggests that the p53 codon 72 polymorphism may be associated with gastric cancer among Asians, and that difference in genotype distribution may be associated with the location, stage, and histological differentiation of gastric cancer. © 2007 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

TP53 Arg72Pro polymorphism and lung canc

TP53 Arg72Pro polymorphism and lung cancer risk: A meta-analysis

✍ Lili Yan; Deqiang Zhang; Chengwen Chen; Yumin Mao; Yi Xie; Yao Li; Yan Huang; Ba 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 461 KB 👁 1 views

## Abstract No clear consensus has been reached on the __TP53__ Arg72Pro polymorphism (G12139C) and lung cancer risk. Thus, a meta‐analysis was conducted to summarize the possible association. There was no statistical association between 12139C (Pro allele) and lung cancer risk in Caucasians compar

The p53 codon 72 polymorphism, sunburns,

The p53 codon 72 polymorphism, sunburns, and risk of skin cancer in US caucasian women

✍ Jiali Han; David G. Cox; Graham A. Colditz; David J. Hunter 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 194 KB

## Abstract The p53 gene is involved in the control of cell‐cycle arrest and apoptosis. The germline Arg72Pro polymorphism alters the protein's biochemical functions, and may confer individual susceptibility to skin cancer. We evaluated the association of the Arg72Pro polymorphism with skin cancer

p53 Codon 72 polymorphism and the risk o

p53 Codon 72 polymorphism and the risk of esophageal squamous cell carcinoma

✍ Wenjun Yang; Yanyan Zhang; Xiuyun Tian; Tao Ning; Yang Ke 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

## Abstract The polymorphisms of the tumor suppressor gene p53 have been extensively investigated in numerous malignant tumors, particularly carcinomas associated with human papillomavirus (HPV) infection. However, the results remain controversial. To address a potential correlation between the p53

Need for clarification of data in the re

Need for clarification of data in the recent meta-analysis about p53 polymorphism and gastric cancer risk

✍ Konstantinos P. Economopoulos; Theodoros N. Sergentanis 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 121 KB

We read with great interest the recent meta-analysis by Zhou et al., 1 which has reached important conclusions about the association between p53 codon 72 polymorphism and gastric cancer risk. Nevertheless, close inspection of the data provided by the authors (Table 1) revealed an issue that is wort

Combination of p53 codon 72 polymorphism

Combination of p53 codon 72 polymorphism and inactive p53 mutation predicts chemosensitivity to 5-fluorouracil in colorectal cancer

✍ Toshiji Tominaga; Makoto Iwahashi; Katsunari Takifuji; Tsukasa Hotta; Shozo Yoko 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 272 KB

## Abstract There are increasing reports showing the clinical significance of the __p53__ polymorphism status in terms of the response to chemotherapy. We investigated whether __p53__ polymorphism and mutation were associated with __in vitro__ sensitivity to 5‐fluorouracil (5‐FU) in patients with c

p53 Codon 72 polymorphism in gastric can

p53 Codon 72 polymorphism in gastric cancer susceptibility in patients with Helicobacter pylori-associated chronic gastritis

✍ Toru Hiyama; Shinji Tanaka; Yasuhiko Kitadai; Masanori Ito; Masaharu Sumii; Masa 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 115 KB

## Abstract __p53__ codon 72, which produces variant proteins with an arginine (Arg) or proline (Pro), has been reported to be associated with cancers of the lung, esophagus and cervix. However, there have been no reports on the __p53__ codon 72 polymorphism in gastric cancer susceptibility in pati